Baligasa, Normia O.

HRN: 21-41-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/29/2022
CEFUROXIME 1.5GM (VIAL)
05/29/2022
06/05/2022
IV
1.5gm
Q8
Empiric For UTI
06/01/2022
CEFUROXIME 500MG (TAB)
06/01/2022
06/07/2022
ORAL
1 Tab BID
7 Days
Urinary Tract Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: